Genome Sequencing Services

With WGS, we decode the entire human genome, offering a comprehensive genetic map that drives transformative healthcare solutions. Whole Genome Sequencing (WGS) is a tool that reveals the complete DNA make-up of an organism. WGS has advantages over multiple traditional methodologies combined as it is simple, precise, fast and flexible

Whole Genome Sequencing (WGS)

With WGS, we decode the entire human genome, offering a comprehensive genetic map that drives transformative healthcare solutions. Whole Genome Sequencing (WGS) is a tool that reveals the complete DNA make-up of an organism. WGS has advantages over multiple traditional methodologies combined as it is simple, precise, fast and flexible.

Tailored Pediatric Care
Leveraging our expertise in rare diseases, Pediatricians can unlock crucial genetic factors related to rare diseases, developmental disorders, and congenital conditions in children.
Data Privacy Assurance
We prioritize your data privacy, employing robust security protocols and ensuring that your genomic data is safeguarded.
Reanalysis for New Variants

We provide reanalysis of patient data for newly identified variants and expanded phenotypes, ensuring that it remains up to date with the latest scientific findings and variant classifications.

Family Data Reuse

We enable the reuse of sequencing data from family members to investigate inherited conditions, providing a comprehensive view of familial genetic patterns and aiding in the diagnosis and management of inherited conditions.

Enhancing Doctors' Efficacy

The perpetual availability of genomic data empowers doctors with the ability to provide ongoing, personalized care, thereby significantly improving patient outcomes and enabling the prescription of more effective, tailored treatments during every patient visit.

Unlock Medical Mysteries with Whole Exome Sequencing (WES)

WES sequencing approach targets the protein coding regions of a genome that is responsible for causing diseases. With a focus on the exome – the functional core of the genome – we offer targeted, cost-effective solutions for clinicians and researchers seeking answers.

Pediatric Excellence

WES shines in pediatric genetics, aiding pediatricians in identifying the genetic roots of developmental delays, intellectual disabilities, and congenital disorders, thereby enabling timely and effective early interventions.

Variant Classification


Our WES includes detailed classification of variants, such as Variants of Uncertain Significance (VUS), providing clinicians with nuanced data to inform treatment and management decisions.

Lifetime Data Availability


The perpetual data access empowers doctors to deliver ongoing, personalized care, greatly improving patient outcomes and enabling more tailored treatments during visits.

Family Studies


WES facilitates the analysis of familial genetic conditions, enabling the identification of causative variants.

Revealing the Symphony of Life: RNA Sequencing Services

Our RNA Sequencing services provide a profound understanding of gene expression, offering invaluable insights into biology, medicine, and beyond.

A transcriptome represents the entire collection of RNA content including mRNA, rRNA and tRNA from a tissue or a cell. It is dynamic and changes in response to genetic and environmental factors. It provides information about the functional elements of the genome and understanding of specific developmental stages of a disease or condition.

Transcriptome Exploration
Dive deep into the transcriptome, capturing dynamic snapshots of gene expression patterns across different conditions, tissues, and time points.
Biomarker Discovery

Uncover pivotal biomarkers linked to diseases to facilitate early diagnosis, informed prognosis, and the development of personalized treatment approaches, enhancing patient care and outcomes.

Drug Discovery
Accelerate drug development by comprehensively analyzing gene expression profiles, pinpointing therapeutic targets, and assessing treatment responses
Decipher Diseases
Researchers and clinicians can unravel the genetic basis of diseases, making significant strides in fields such as oncology, immunology, and neurology.
Research Opportunities
We facilitate collaborative opportunities for researchers and clinicians to explore genomic data, driving forward scientific discovery and enabling the development of novel therapeutic approaches.

Harnessing the Power of Data

We excel in the intricate art of handling and deciphering complex biological data. Our forte lies in transforming this intricate data into practical, actionable insights, paving the way for groundbreaking advancements in scientific research.

Epigenomics Analysis

This involves studying genome modifications that impact gene expression without changing the DNA sequence, aiding our understanding of gene regulation in development, diseases, and biological processes.

Metagenomics Analysis

This includes analyzing genetic material from environmental samples, profiling genetic diversity, functionality, and microbial interactions in the sample.

Comparative Genomics


This analyzes genomic sequences to understand evolution, identify conserved regions, and reveal species-specific traits or diseases.

Data Mining & Machine Learning


These techniques analyze genomics data to uncover patterns and genetic variant associations with phenotypes and diseases, and train predictive models, aiding in biomarker discovery, disease classification, and personalized medicine.







10x and 30x

40x to 250x

40 - 80 million reads, WTS


2 - 3 Weeks

Varies as per sequencing and samples

Varies as per sequencing and samples


2X 150 PE Sequencing

2X 150 PE Sequencing

2X 150 PE Sequencing

Sequencing Platform

illumina Novaseq 6000

illumina Novaseq 6000

illumina Novaseq 6000


90 & 120 GB

4-18 GB (Depends on the coverage)

4-18 GB (Depends on the coverage)

Sample Types


Blood, Tissue, Cf DNA, DNA

Blood, tissue, Cells, RNA

Our partner labs hold a multitude of prestigious accreditations, signifying commitment to upholding the highest standards of quality and reliability in the work

With a decade of diverse experience under his belt, Sameer Malik, an alumnus of the Delhi School of Economics, brings a robust blend of business strategy, finance, operations, and sales expertise to Vgenomics. From kick starting his career at KPMG to founding and scaling an e-commerce startup to over $1.5 million in annual revenues, and further contributing to the startup ecosystem through his involvement in Startup Nexus and Token Amigo, Sameer has navigated through various industries, consistently playing to his strategic and operational strengths. His rich entrepreneurial journey and strategic acumen are now channeled towards advancing Vgenomics' mission in the realm of rare inborn diseases diagnostics and therapeutic solutions.

A translational biologist based in Silicon Valley, Dr. Lal brings her expertise in data science, translational medicine, clinical biomarker, and CDx implementation across all phases of clinical trials development to Vgenomics. With over 150 patents to her name, she has substantial experience in regulatory interactions with both the drug and device divisions of the FDA, and companion diagnostics (Dx) programs.

After earning her doctorate from International Center of Genetic Engineering and Biotechnology (ICGEB), Dr. Sardar embarked on a mission to transform her research findings into practical applications that could benefit rare disease patients globally. She noticed a gap in dedicated solutions for the burgeoning hub of rare diseases in India, particularly those affecting children, and co-founded Vgenomics with Dr. Preeti to develop affordable diagnostics and therapeutic solutions.

Open chat
✉ Hey! Need Help?
Can we help you?